Article thumbnail

Sputum-smear-negative pulmonary tuberculosis: Controlled trial of 3-month and 2-month regimens of chemotherapy

By Hong Kong Hong Kong Chest Service, Madras Tuberculosis Research Centre and London British Medical Council

Abstract

Of 1072 Chinese patients with radiographically active pulmonary tuberculosis and no microscopic evidence of acid-fast bacilli in sputum examinations, only 691 (64%) were sputum-culture negative. All patients were randomly allocated to selective chemotherapy (antituberculosis chemotherapy not being started until the activity of the disease had been confirmed), to daily streptomycin, isoniazid, rifampicin, and pyrazinimide for 2 months or 3 months, or to a standard 12-month control regimen. During the subsequent 12 months, 64% of the patients in the selective chemotherapy series started antituberculosis chemotherapy. Both 2-month and 3-month regimens were inadequate for patients whose pretreatment sputum cultures were positive (relapse-rates 14% and 7%, respectively, in patients with drug-sensitive strains) but in the patients whose first cultures were negative the relapse-rate was only 1% after both short-term regimens

Topics: Clinical Research, Epidemiological Research
Publisher: 'Elsevier BV'
Year: 1979
OAI identifier: oai:eprints.nirt.res.in:135
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • https://eprints.nirt.res.in//1... (external link)
  • https://eprints.nirt.res.in//1... (external link)
  • Suggested articles


    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.